Substances · Phenethylamine derivatives
IPPH (Isopropylphenidate)
- Preferred name
- IPPH (Isopropylphenidate)
- IUPAC name
- propan-2-yl 2-phenyl-2-piperidin-2-ylacetate
- Parent CAS number (reference)
- 93148-46-0
- Molecular formula
- C16H23NO2
- Molecular weight
- 261.36 g/mol
- InChIKey
- AZVPADMEIMLODT-UHFFFAOYSA-N
- PubChem
- CID 68314762
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
Isopropylphenidate IPPH IPH IPPD
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
IPPH (Isopropylphenidate)
Receptor Telemetry & Mechanism of Action
IPPH is the isopropyl ester analogue of methylphenidate and a dopamine/norepinephrine reuptake inhibitor. The bulkier ester is associated, in anecdotal comparison and in the lower intensity of the PsychonautWiki common band relative to its milligram size, with a smoother, less jittery stimulant than 4F-MPH or racemic methylphenidate. It does not release serotonin and it is not an entactogen. The reference IUPAC is the non-stereospecific name propan-2-yl 2-phenyl-2-piperidin-2-ylacetate.
Biotransformation & Active Metabolites
Ester hydrolysis yields the corresponding phenylpiperidineacetic acid, analogous to ritalinic acid, which is not the active stimulant. IPPH is not a prodrug of 4F-MPH. CAS 93148-46-0 is this isopropyl ester, not methylphenidate and not 4F-MPH (CAS 1354631-33-6).
Temporal Pharmacokinetics
Milder functional stimulant. Wakefulness and focus with less peripheral jitter than 4F-MPH, still a real NDRI with a crash and insomnia if pushed.
- Onset 10–30 minutes
- Peak Window 1.5–2.5 hours
- Total Window 3.5–6 hours
- Residual / Half-Life PsychonautWiki's summary sheet does not list a separate after-effect interval. Residual stimulation commonly fades across the offset, but a strong amount still disrupts sleep. Human half-life is not established.
Threshold 2 mg, light 5–15 mg, common 15–25 mg, strong 25–45 mg, heavy above 45 mg. The strong band is wide compared with 4F-MPH, where heavy already begins at 20 mg. That difference is why the two powders cannot share a scoop. Total duration is shorter than 4F-MPH (about 3.5–6 hours).
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
2 mg
A faint increase in alertness.
Minimal pulse change.
5–15 mg
Gentle focus and wakefulness without much mood elevation.
Mild appetite loss and dry mouth.
15–25 mg
Clear functional stimulation and sociable energy with less edge than the same person's 4F-MPH experience.
Increased heart rate, appetite suppression, and light bruxism.
25–45 mg
Forced wakefulness, anxiety, and scattered attention. The wide strong band is not a license to sit at the top of it.
Tachycardia, vasoconstriction, sweating, and a sharper crash.
45 mg+
Agitation and compulsive repeated exposure. This is still far below a casual 'extra' if someone is thinking in 4-FA milligrams, and far above a 4F-MPH dose.
Hypertensive strain, tremor, severe insomnia, and seizure risk with tramadol or an MAOI.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.
Adds extreme vasoconstriction and seizure risk on top of an already raised heart rate and blood pressure.
Both lower the seizure threshold. Tramadol also adds serotonin reuptake inhibition, which is dangerous with the serotonergic releasers in this set.
Elevated Hazard — Avoid
Additive tachycardia, hypertension, bruxism, and post-session anxiety without restoring a faded peak.
The stimulant hides sedation. When it drops, the depressant remains.
Caution / Receptor Attenuation
Additive NDRI effect. 10 mg of 4F-MPH is already a common dose of that drug and is not a small add-on.
Can turn a mild functional stimulant into an anxious one on the offset.
Structural Isomer & Sibling Comparison
IPPH is the smoother isopropyl phenidate: common 15–25 mg oral, about 3.5–6 hours, heavy above 45 mg. 4F-MPH is fluorinated methylphenidate, common only 10–15 mg, heavy above 20 mg, with a much longer residual tail. Methylphenidate is the methyl ester and is not dosed from this chart. Neither is 2-FMA, which is a releaser rather than an uptake inhibitor and lasts 7–9 hours.
Physicochemical Stability & Storage
Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.
Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.
Cross-Tolerance & Dependence Profile
NDRI tolerance and cross-tolerance with methylphenidate, 4F-MPH, and amphetamines. PsychonautWiki's class note is a half-reduction in about 3–7 days and a baseline approach in 1–2 weeks. Psychological dependence shows up as needing the afternoon dose to feel normal. The crash is fatigue and low motivation, not a seizure withdrawal. The wide strong band (25–45 mg) is where repeated daily use quietly settles.
Chemical Architecture & Structural Profile
IPPH (Isopropylphenidate) (propan-2-yl 2-phenyl-2-piperidin-2-ylacetate) is a reference compound belonging to the Phenethylamine derivatives class, characterized by the molecular formula C16H23NO2 and a molar mass of 261.36 g/mol. The parent molecule is indexed under CAS registry number 93148-46-0 and in the NCBI PubChem database as CID 68314762 (Standard InChIKey: AZVPADMEIMLODT-UHFFFAOYSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), IPPH (Isopropylphenidate) is indexed within the Substituted phenidates structural group. Toxicological notes (PsychonautWiki): exact toxic threshold is unknown. Dependence liability (PsychonautWiki): moderately addictive with a high potential for abuse. Documented cross-tolerance class: dopamine, stimulant. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- Federal Register of Legislation — Therapeutic Goods (Poisons Standard) — Australian Government (2026-11-12)